{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:47:53Z","timestamp":1784180873257,"version":"3.55.0"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Worldwide, depression and bipolar disorder affect a large and growing number of people. However, current pharmacotherapy options remain limited. Despite adequate treatment, many patients continue to have subsyndromal symptoms, which predict relapse in bipolar illness and often result in functional impairments. Aspirin, a common nonsteroidal anti-inflammatory drug (NSAID), has purported beneficial effects on mood symptoms, showing protective effects against depression in early cohort studies. This systematic review thus aimed to investigate the role of aspirin in mood disorders. Using the keywords (aspirin or acetylsalicy* or asa) and (mood or depress* or bipolar or mania or suicid*), a comprehensive search of PubMed, EMBASE, Medline, PsycINFO, Clinical Trials Register of the Cochrane Collaboration Depression, Anxiety and Neurosis Group (CCDANTR), Clinicaltrials.gov and Google Scholar databases found 13,952 papers published in English between 1 January 1988 and 1 May 2019. A total of six clinical studies were reviewed. There were two randomized, placebo-controlled, double-blind trials and populations drawn from two main cohort studies (i.e., the Geelong Osteoporosis Study and the Osteoarthritis Initiative study). Using a random-effects model, the pooled hazard ratio of the three cohort studies was 0.624 (95% confidence interval: 0.0503 to 1.198, p = 0.033), supporting a reduced risk of depression with aspirin exposure. Overall, the dropout rates were low, and aspirin appears to be well-tolerated with minimal risk of affective switch. In terms of methodological quality, most studies had a generally low risk of bias. Low-dose aspirin (80 to 100 mg\/day) is safe, well-tolerated and potentially efficacious for improving depressive symptoms in both unipolar and bipolar depression. Due to its ability to modulate neuroinflammation and central nervous system processes, aspirin may also have valuable neuroprotective and pro-cognitive effects that deserve further exploration. Further randomized, controlled trials involving the adjunctive use of aspirin should be encouraged to confirm its therapeutic benefits.<\/jats:p>","DOI":"10.3390\/brainsci9110296","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T05:18:26Z","timestamp":1572499106000},"page":"296","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical Role of Aspirin in Mood Disorders: A Systematic Review"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-2513","authenticated-orcid":false,"given":"Qin Xiang","family":"Ng","sequence":"first","affiliation":[{"name":"MOH Holdings Pte Ltd., 1 Maritime Square, Singapore 099253, Singapore"},{"name":"Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnapriya","family":"Ramamoorthy","sequence":"additional","affiliation":[{"name":"MOH Holdings Pte Ltd., 1 Maritime Square, Singapore 099253, Singapore"},{"name":"Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayren","family":"Loke","sequence":"additional","affiliation":[{"name":"MOH Holdings Pte Ltd., 1 Maritime Square, Singapore 099253, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Wei Liang","family":"Lee","sequence":"additional","affiliation":[{"name":"Fitzwilliam College, University of Cambridge, Storey\u2019s Way, Cambridge CB3 0DG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Song","family":"Yeo","sequence":"additional","affiliation":[{"name":"National University Hospital, National University Health System, Singapore 119074, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan Yutong","family":"Lim","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanandan","family":"Sivalingam","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, Singapore 539747, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2017). Depression and Other Common Mental Disorders: Global Health Estimates, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jclp.10174","article-title":"Dysthymia and chronic depression: Introduction, classification, risk factors, and course","volume":"59","author":"Klein","year":"2003","journal-title":"J. Clin. Psychol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jakobsen, J.C., Katakam, K.K., Schou, A., Hellmuth, S.G., Stallknecht, S.E., Leth-M\u00f8ller, K., Iversen, M., Banke, M.B., Petersen, I.J., and Klingenberg, S.L. (2017). Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry, 17.","DOI":"10.1186\/s12888-016-1173-2"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.10m06191","article-title":"Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications","volume":"72","author":"Khin","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ng, Q.X., Yeo, W.S., and Sivalingam, V. (2019). Lithium-associated Renal Dysfunction: To Stop or Not to Stop?. Bipolar Disord.","DOI":"10.1111\/bdi.12853"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","article-title":"Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder","volume":"22","author":"Popovic","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1055\/s-0031-1273765","article-title":"Comparison of pre-episode and pre-remission states using mood ratings from patients with bipolar disorder","volume":"44","author":"Bauer","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.280.5367.1268","article-title":"Aspirin-like molecules that covalently inactivate cyclooxygenase-2","volume":"280","author":"Kalgutkar","year":"1998","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000319530","article-title":"Clinical implications of the cytokine hypothesis of depression: The association between use of statins and aspirin and the risk of major depression","volume":"79","author":"Pasco","year":"2010","journal-title":"Psychother. Psychosom."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_16","unstructured":"Wells, G.A. (2019, June 29). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non Randomised Studies in Meta-Analyses, Available online: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1002\/gps.4767","article-title":"Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years","volume":"33","author":"Veronese","year":"2018","journal-title":"Int. J. Geriatr. Psychiatr"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bdi.12108","article-title":"Aspirin for treatment of lithium-associated sexual dysfunction in men: Randomized double-blind placebo-controlled study","volume":"15","author":"Saroukhani","year":"2013","journal-title":"Bipolar Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: An adaptive, 2 \u00d7 2 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","article-title":"Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder","volume":"82","author":"Stolk","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Williams, L.J., Pasco, J.A., Mohebbi, M., Jacka, F.N., Stuart, A.L., Venugopal, K., O\u2019Neil, A., and Berk, M. (2016). Statin and aspirin use and the risk of mood disorders among men. Int. J. Neuropsychopharmacol., 19.","DOI":"10.1093\/ijnp\/pyw008"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11920-012-0323-6","article-title":"An update on antidepressant use in bipolar depression","volume":"14","author":"Sidor","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jnr.10192","article-title":"Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat","volume":"68","author":"Casolini","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_25","first-page":"57","article-title":"The treatment of bipolar depression","volume":"61","author":"Compton","year":"2000","journal-title":"J. Clinic. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1753425911421512","article-title":"Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells","volume":"18","author":"Nahman","year":"2012","journal-title":"Innate Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nlm.2017.03.017","article-title":"Lithium and memantine improve spatial memory impairment and neuroinflammation induced by \u03b2-amyloid 1-42 oligomers in rats","volume":"141","author":"Budni","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(02)03164-5","article-title":"The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: Implications for Alzheimer\u2019s disease","volume":"951","author":"Hoozemans","year":"2002","journal-title":"Brain Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1\u03b2 in bipolar disorder","volume":"36","author":"Olsson","year":"2011","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E7408","DOI":"10.1073\/pnas.1802021115","article-title":"Aspirin binds to PPAR\u03b1 to stimulate hippocampal plasticity and protect memory","volume":"115","author":"Patel","year":"2018","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/pcn.12463","article-title":"Cognitive dysfunction in major depression and bipolar disorder: A ssessment and treatment options","volume":"71","author":"MacQueen","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chang, C.W., Horng, J.T., Hsu, C.C., and Chen, J.M. (2016). Mean daily dosage of aspirin and the risk of incident Alzheimer\u2019s dementia in patients with type 2 diabetes mellitus: A nationwide retrospective cohort study in Taiwan. J. Diabetes Res., 2016.","DOI":"10.1155\/2016\/9027484"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.06.007","article-title":"Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats","volume":"142","author":"Lu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.0804477","article-title":"Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction","volume":"78","author":"Giuliani","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","article-title":"Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials","volume":"227","author":"Rosenblat","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.12.015","article-title":"Minocycline does not evoke anxiolytic and antidepressant-like effects in C57BL\/6 mice","volume":"301","author":"Vogt","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_37","first-page":"943","article-title":"Risk assessment and aspirin use in Asian and Western populations","volume":"6","author":"Gao","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0197-4580(02)00188-4","article-title":"Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study","volume":"24","author":"Jonker","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/CIRCULATIONAHA.116.025760","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in patients with type 2 diabetes mellitus: 10-year follow-up of a randomized controlled trial","volume":"135","author":"Saito","year":"2017","journal-title":"Circulation"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/9\/11\/296\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:13Z","timestamp":1760189413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/9\/11\/296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["brainsci9110296"],"URL":"https:\/\/doi.org\/10.3390\/brainsci9110296","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}